The role of Rel/NF-κB transcription factors in B lymphocyte survival

Seminars in Immunology

Volumn 15, Issue 3, 2003, Pages 159-166

  Gerondakis, Steve ^a   Strasser, Andreas ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Apoptosis; B cells; Bcl 2; NF B

Indexed keywords

BIM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR;

ANTIGENICITY; APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CELL TYPE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; LYMPHOPOIESIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0742304482     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-5323(03)00036-8     Document Type: Article

References (45)

1. Baldwin A.S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Ann. Rev. Immunol. 14:1996;649-683.
2. Whiteside S.T., Israel A. IκB proteins: structure, function and regulation. Semin. Cancer Biol. 8:1997;75-82.
3. Karin M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene. 18:1999;6867-6874.
4. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:2000;621-663.
5. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109:2002;S81-S96.
6. Dejardin E., Droin N.M., Delhase M., Hass E., Cao Y., Makris C.et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity. 17:2002;525-535.
7. Claudio E., Brown K., Park S., Wang H., Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3:2002;958-965.
8. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M.et al. BAFF/BLys receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity. 10:2002;515-524.
9. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G.et al. Activation by IKKα of a second evolutionary conserved NF-κB signaling pathway. Science. 293:2001;1495-1499.
10. Strasser A., Harris A.W., Huang D.-C., Kramer P.H., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136-6147.
11. Strasser A., O'Connor L., Dixit V.M. Apoptosis signaling. Ann. Rev. Biochem. 69:2000;217-245.
12. Mak T.W., Yeh W.-C. Signaling for survival and apoptosis in the immune system. Arthritis Res. 4:2002;S243-S252.
13. Osmond D.G. The turnover of B cell populations. Immunol. Today. 14:1993;34-37.
14. Grumont R.J., Gerondakis S. The subunit composition of NF-κB complexes change during B cell development. Cell Growth Differ. 5:1994;1321-1331.
15. Gerondakis S., Grossmann M., Nakamura Y., Pohl T., Grumont R. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenetics and knockouts. Oncogene. 18:1999;6888-6895.
16. Franzoso G., Carlson L., Poljak L., Shores E.W., Epstein S., Leonardi A.et al. Mice deficient in nuclear factor (NF)-κB2/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:1998;147-159.
17. Cariappa A., Liou H.-C., Horwitz B.H., Pillai S. Nuclear factor κB is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192:2000;1175-1182.
18. Pohl T., Gugasyan R., Grumont R.J., Strasser A., Metcalf D., Tarlinton D.et al. The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;4514-4519.
19. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W.et al. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
20. Kaisho T., Takeda K., Tsujimura T., Kawai T., Nomura F., Terada N.et al. IκB kinase α is essential for mature B cell development and function. J. Exp. Med. 193:2001;417-426.
21. Pasaparakis M., Schmidt-Supprian M., Rajewsky K. IκB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196:2002;743-752.
22. Horwitz B.H., Scott M.L., Cherry S.R., Bronson R.T., Baltimore D. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity. 6:1997;765-772.
23. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D.et al. Requirement for NF-κB in osteoclast and B cell development. Genes Dev. 11:1997;3482-3496.
24. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. 2000.
25. Gugasyan R., Grumont R., Grossmann M., Nakamura Y., Pohl T., Nesic D.et al. Rel/NF-κB transcription factors: key mediator s of B-cell activation. Immunol. Rev. 176:2000;134-140.
26. Chao D.T., Korsmeyer S.J. BCL-2 family: regulators of cell death. Ann. Rev. Immunol. 16:1998;395-419.
27. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Nakayama K.et al. Massive cell death of immature hemopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1995;1506-1510.
28. Grillot D.A., Merino R., Pena J.C., Fanslow W.C., Finkelman F.D., Thompson C.B.et al. Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:1996;381-391.
29. Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9136-9141.
30. Tomayko M.M., Cancro M.P. Long-lived B cells are distinguished by elevated expression of A1. J. Immunol. 160:1998;107-111.
31. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D.et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation humoral immunity and interleukin-2 expression. Genes Dev. 9:1995;1965-1977.
32. Hamasaki A., Sendo F., Nakayama K., Ishida N., Negishi I., Hatakeyama S. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J. Exp. Med. 188:1998;1985-1992.
33. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulmiant lymphoid apoptosis polycystic kidneys and hypopigmented hair. Cell. 75:1993;229-240.
34. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2:2002;465-475.
35. Macay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P.et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1999;1697-1710.
36. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R.et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B-cell maturation in mice elacking BLys. Immunity. 15:2001;289-302.
37. Yan M., Zhang Z., Brady J.R., Schilbach S., Fairbrother W.J., Dixit V.M. Identification of a novel receptor for B-lymphocyte stimulator that is mutated in a mouse strain with severe B-cell deficiency. Curr. Biol. 11:2001;1547-1552.
38. Lam K.P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting result sin rapid cell death. Cell. 90:1997;1073-1083.
39. Ruland J., Duncan G.S., Elia A., Barrantes I., Nguyen L., Plyte S.et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell. 104:2001;33-42.
40. Grumont R.J., Rourke I.J., Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:1999;400-411.
41. Owyang A.M., Tumang J.R., Schram B.R., Hsia C.Y., Behrens T.W., Rothstein T.L.et al. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated apoptosis. J. Immunol. 167:2001;4948-4956.
42. Gerondakis S. Unpublished results.
43. Adams J.M., Cory S. The bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
44. Bouillet P., Metcalf D., Huang D.-C., Tarlinton D.M., Kay T.W., Kontgen F.et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis and to prevent autoimmunity. Science. 286:1999;1735-1738.
45. Bouillet P., Purton J.F., Godfrey D.J., Zhang L.C., Coultas L., Puthalakath H.et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926.